IntrinsicIntrinsic
← Scroll for more →

Financial Statements — OGEN

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents3.866.114.4011.401.973.420.863.141.352.073.485.776.479.1611.4313.9517.8721.3727.2729.95
Short-term Investments--4.004.00----------------------------------
Total Current Assets5.497.4910.0712.712.143.871.474.111.622.443.877.818.1011.7014.2916.5219.8623.0927.7130.54
Property, Plant & Equipment--------------------0.000.050.100.110.120.130.110.120.050.03
Total Non-current Assets*0.000.000.000.000.000.000.001.091.091.091.100.090.370.430.470.530.500.550.520.56
Total Assets5.497.4910.0712.712.143.871.475.202.713.534.977.908.4612.1314.7617.0520.3523.6528.2331.09
Accounts Payable1.821.251.562.481.271.181.361.611.380.781.480.880.951.471.120.951.281.090.951.52
Total Current Liabilities--------------------1.801.401.141.781.601.571.461.411.452.20
Total Non-current Liabilities*--------------------0.000.000.070.100.150.200.220.250.300.35
Total Liabilities*1.821.311.792.874.273.731.682.131.380.911.801.401.211.891.751.781.681.661.742.54
Retained Earnings(231.36)(228.83)(226.63)(224.34)(221.28)(219.00)(216.79)(213.44)(210.97)(208.67)(206.22)(193.47)(191.46)(188.41)(185.56)(183.32)(179.45)(175.87)(171.27)(168.98)
Total Stockholder Equity3.676.188.289.83(2.13)0.14(0.21)3.081.332.633.176.507.2610.2413.0115.2718.6721.9926.4928.55
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue--------------0.010.01--0.000.010.010.020.000.090.030.02----
Research & Development1.180.650.670.930.450.341.670.880.910.6611.040.772.011.671.412.782.593.291.313.55
Selling, General & Admin1.421.611.832.191.261.681.691.561.401.801.751.331.121.250.881.221.041.331.080.85
Total Operating Expenses2.592.262.503.121.712.033.362.442.312.4612.802.103.122.922.303.993.634.632.394.39
Operating Income(2.59)(2.26)(2.50)(3.12)(1.71)(2.03)(3.36)(2.44)(2.31)(2.46)(12.80)(2.09)(3.11)(2.90)(2.30)(3.91)(3.60)(4.61)(2.30)(4.39)
Interest Expense------------------0.010.010.010.000.000.010.010.000.000.010.01
Pretax Income(2.58)(2.22)------(2.22)(3.35)(2.46)(2.31)(2.45)(12.75)(2.01)(3.05)(2.84)(2.24)(3.87)(3.59)(4.59)(2.29)(4.38)
Tax Provision(0.05)(0.02)------------------------------------
Net Income(2.53)(2.20)(2.29)(3.07)(2.27)(2.22)(3.35)(2.46)(2.31)(2.45)(12.75)(2.01)(3.05)(2.84)(2.24)(3.87)(3.59)(4.59)(2.29)(4.38)
Basic EPS(0.57)(0.51)0.62(1.96)(3.10)(0.12)(0.01)(0.38)(0.51)(0.70)(5.41)(0.85)(1.51)(1.41)(7.00)(0.03)(0.03)(0.04)----
Diluted EPS(0.57)(0.51)0.62(1.96)(3.10)(0.12)(0.01)(0.38)(0.51)(0.70)(5.48)(0.85)(1.51)--------------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(2.19)(2.20)(2.84)(2.98)(1.31)(2.11)(2.02)(1.97)(1.54)(3.06)(1.10)(1.50)(2.58)(2.11)(2.43)(3.78)(3.38)(5.64)(1.88)(5.18)
Capital Expenditures----------------------------0.000.040.000.090.020.02
Free Cash Flow*----------------------------(2.44)(3.81)(3.38)(5.72)(1.90)(5.20)
Investing Cash Flow0.004.00----------------(1.00)0.06-----0.00(0.04)0.00(0.08)(0.02)(0.02)
Financing Cash Flow(0.06)(0.09)(0.17)12.41(0.13)4.67(0.26)3.770.821.65(0.18)0.73(0.11)(0.16)(0.09)(0.10)(0.12)(0.18)(0.78)0.58
← Scroll for more columns →

* Derived from reported values